Isabela Ramirez-Velez
Overview
Explore the profile of Isabela Ramirez-Velez including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
5
Citations
6
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ramirez-Velez I, Namjoshi A, Effiong U, Peppas N, Belardi B
ACS Nano
. 2024 Aug;
18(32):21038-21051.
PMID: 39096293
A general platform for the safe and effective oral delivery of biologics would revolutionize the administration of protein-based drugs, improving access for patients and lowering the financial burden on the...
2.
Effiong U, Khairandish H, Ramirez-Velez I, Wang Y, Belardi B
Nat Commun
. 2024 Jul;
15(1):5840.
PMID: 38992021
Within a shared cytoplasm, filamentous actin (F-actin) plays numerous and critical roles across the cell body. Cells rely on actin-binding proteins (ABPs) to organize F-actin and to integrate its polymeric...
3.
Effiong U, Khairandish H, Ramirez-Velez I, Wang Y, Belardi B
bioRxiv
. 2023 Nov;
PMID: 37961502
Within a shared cytoplasm, filamentous actin (F-actin) plays numerous and critical roles across the cell body. Cells rely on actin-binding proteins (ABPs) to organize F-actin and to integrate its polymeric...
4.
Roy S, Acosta J, Karak M, Ramirez-Velez I, Torikai K, Ren D, et al.
ACS Omega
. 2023 Oct;
8(41):37798-37807.
PMID: 37867724
Detrimental biofilms of bacterial pathogens cause chronic infections with a high-level tolerance to antibiotics. To identify new control agents, we synthesized and tested a total of 14 tetronamides (including 5...
5.
Ramirez-Velez I, Belardi B
Adv Drug Deliv Rev
. 2023 Jun;
199:114905.
PMID: 37271282
As biologics used in the clinic outpace the number of new small molecule drugs, an important challenge for their efficacy and widespread use has emerged, namely tissue penetrance. Macromolecular drugs...